Allegra Ad State Law Portrayal Misleading When Applied To Benadryl – W-L
This article was originally published in The Tan Sheet
Executive Summary
A DTC radio ad for Aventis' Rx antihistamine Allegra (fexofenadine) misrepresents state laws concerning driving impairment when referring to Pfizer/Warner-Lambert Consumer Group's Benadryl, the firm alleges in a case to appear in an upcoming NAD Case Reports
You may also be interested in...
Claritin Pollen Chaser Bus Campaign Drives Home Antihistamine Safety
Schering-Plough's Pollen Chaser marketing campaign for Claritin, breaking in time for the spring allergy season, focuses on the antihistamine's non-sedating characteristics
Pfizer, Aventis Still See Wiggle Room On FDA-Mandated Switches
FDA likely will face a legal challenge regardless of whether the agency decides to implement mandated Rx-to-OTC switches or chooses a more indirect policy yielding similar results, according to comments made by Aventis and Pfizer executives
OTC/Rx Sodium Phosphate Laxative Claim Dispute Referred By NAD
InKline Pharmaceuticals, which sells Rx sodium phosphate tablets, has declined to participate in the NAD self-regulatory forum, maintaining NAD is not the proper authority to review its marketing claims